Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b–2 study
Hervé Tilly, Franck Morschhauser, Nancy L. Bartlett, Amitkumar Mehta, Gilles Salles, Corinne Haioun, Javier Munoz, Andy I. Chen, Kathryn Kolibaba, Dan Lu, Mark Yan, Elicia Penuel, Jamie Hirata, Calvin Lee, Jeff P. Sharman
Dive into the research topics of 'Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b–2 study'. Together they form a unique fingerprint.